Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Rodney Basler

Dermatology Lincoln, NE Medical Doctor

NPI 1700984929 CMS profile 213168

2625 Stockwell St, Lincoln, NE 68502

Open in the dashboard

General payments

$4,609

289 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$4,761 paid to institutions, not to them · program years 2019–2020

Through program year 2022, Rodney Basler of Lincoln, NE is reported in the CMS Open Payments database as having received $4,609 across 289 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,761 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 63rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $27 2
2021 General $182 11
2020 General $1,713 101
2019 General $2,688 175

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rodney Basler
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Rodney Basler were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Rodney Basler Dermatology median Middle half National median
2019 $2,688 $454 $129–$1,240 $163
2020 $1,713 $235 $81–$756 $114
2021 $182 $377 $108–$1,108 $132
2022 $27 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. AbbVie, Inc. $1,184 60 payments
  2. Janssen Biotech, Inc. $677 37 payments
  3. Amgen Inc. $400 29 payments
  4. Galderma Laboratories, L.P. $275 26 payments
  5. Regeneron Healthcare Solutions, Inc. $263 13 payments
  6. Lilly USA, LLC $217 16 payments
  7. Sun Pharmaceutical Industries Inc. $201 14 payments
  8. Ortho Dermatologics, a division of Bausch Health US, LLC $185 13 payments
  9. UCB, Inc. $163 9 payments
  10. Pfizer Inc. $162 14 payments
  11. Other $883 58 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Food and Beverage $4,312 285 payments
  2. Education $297 4 payments
Products named General payments · program years 2019–2022
  1. HUMIRA $995 51 payments
  2. SKYRIZI $593 38 payments
  3. TREMFYA $564 27 payments
  4. STELARA $285 27 payments
  5. DUPIXENT $263 13 payments
  6. EPIDUO FORTE $252 23 payments
  7. TALTZ $217 16 payments
  8. Cimzia $163 9 payments
  9. EUCRISA $162 14 payments
  10. Otezla $161 10 payments
  11. Other $2,483 194 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

289 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Nebraska

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record